Form 4: Tango Therapeutics General Counsel Sells Shares to Cover Tax Obligations

Douglas Barry, General Counsel of Tango Therapeutics, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Douglas Barry, the General Counsel of Tango Therapeutics, sold shares of the company's common stock on February 4th and 5th, 2025.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On February 4th, 2,774 shares were sold at a weighted average price of $2.988 per share.
• On February 5th, 2,556 shares were sold at a weighted average price of $3.1614 per share.
• Following these transactions, Barry directly owns 66,014 shares of Tango Therapeutics.
• The sales were automatic under the company's 'sell-to-cover' policy and not at Barry's discretion.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports the sale of shares to cover tax obligations, a routine event. There's no indication of positive or negative implications for the company's performance or outlook.

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

Sales of shares by company insiders are common and often related to compensation and tax obligations. The 'sell-to-cover' policy is a standard practice to manage these obligations.

Comparison to Industry Standards

• Many companies, including those in the biotechnology sector like Tango Therapeutics, use restricted stock units (RSUs) as part of their compensation packages.
• The 'sell-to-cover' mechanism is a common practice among companies offering RSUs, similar to companies like Amgen or Gilead Sciences, to facilitate tax payments upon vesting.
• The volume of shares sold is relatively small compared to the total outstanding shares, which is typical for these types of transactions.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but the explanation provided mitigates any potential negative perception.

Key Dates

Keywords

Tango Therapeutics, TNGX, Form 4, Douglas Barry, General Counsel, Share Sale, Tax Withholding, Restricted Stock Units, Sell-to-Cover